Ancillary Laboratory Protocol for Collecting Diagnostic Material on Patients Considered for Studies of Multiple Myeloma and Other Plasma Cell Disorders
This study is being done to collect and study blood and bone marrow cells to either determine if one of ECOG’s treatment trials is right for the participant or to study the biology of blood or bone marrow disorders. Participants in this study have been diagnosed with Multiple Myeloma and other plasma cell disorders. This study may determine a participant’s eligibility for a Treatment Trial. Treatment will depend on the type of blood/bone marrow cell that is affected by this disease. Some treatment strategies may require that diseased cells (such as plasma cells) have certain properties, for instance, express a certain chromosome abnormality that may affect treatment outcome.
Back to Clinical Trials list